RhumbLine Advisers’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-28,769
Closed -$34.2K 4281
2025
Q1
$34.2K Buy
28,769
+3,143
+12% +$5.02K ﹤0.01% 3654
2024
Q4
$52.8K Buy
25,626
+10,826
+73% +$25.2K ﹤0.01% 3643
2024
Q3
$37.4K Buy
14,800
+7,374
+99% +$24.1K ﹤0.01% 3732
2024
Q2
$31.7K Buy
+7,426
New +$47.8K ﹤0.01% 3792

Other funds holding GUTS

RhumbLine Advisers's GUTS Position: Q2 2025 in Review

RhumbLine Advisers sold out of Fractyl Health (GUTS) in Q2 2025, closing a stake of 28,769 shares — an estimated $34.2K sold.

RhumbLine Advisers first reported a position in GUTS in Q2 2024 and held it in 4 quarters. The position peaked at $52.8K in Q4 2024. 62 funds tracked by Wall St. Rank hold GUTS as of Q2 2025.

  • RhumbLine Advisers reported no remaining Fractyl Health position as of Q2 2025 after selling out during the quarter.
  • RhumbLine Advisers sold 28,769 Fractyl Health shares in Q2 2025, an estimated $34.2K.
  • RhumbLine Advisers first reported a position in Fractyl Health in Q2 2024 and held it in 4 quarters.
  • RhumbLine Advisers's Fractyl Health position peaked at $52.8K in Q4 2024.
  • 62 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2025.

Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.